{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:59:26Z","timestamp":1770991166267,"version":"3.50.1"},"reference-count":14,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1492,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1756-185x.2011.01629.x","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T09:11:11Z","timestamp":1312535471000},"page":"e33-e37","source":"Crossref","is-referenced-by-count":37,"title":["Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout"],"prefix":"10.1111","volume":"14","author":[{"given":"Ai P.","family":"TRAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"EDELMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncprheum0556","article-title":"The changing epidemiology of gout","volume":"3","author":"Roddy","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.bor.0000209435.89720.7c","article-title":"New insights into gout epidemiology","volume":"18","author":"Mikuls","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.4049\/jimmunol.138.10.3213","article-title":"Interleukin 1 (IL1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL1","volume":"138","author":"Di Giovine","year":"1987","journal-title":"J Immunol"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB6|cit6","doi-asserted-by":"crossref","DOI":"10.1186\/ar2509","article-title":"Developments in the scientific and clinical understanding of gout","volume":"10","author":"So","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB7|cit7","first-page":"74","article-title":"IL-1 targeted therapy in autoinflammatory diseases","volume":"6","author":"Hoffman","year":"2008","journal-title":"Int J Adv Rheumatol"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo controlled, mono-sequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/ard.2007.073759","article-title":"Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra","volume":"66","author":"McGonagle","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.semarthrit.2010.03.001","article-title":"Anakinra\u2019s efficacy is variable in refractory gout: report of ten cases","volume":"40","author":"Chen","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/art.24694","article-title":"Case of anakinra as a steroid-sparing agent for gout inflammation","volume":"61","author":"Gratton","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB13|cit13","volume-title":"National Hospital Cost Data Collection. Cost report round 12 (2007-2008)","author":"The Commonwealth Department of Health and Aging","year":"2009"},{"key":"10.1111\/j.1756-185X.2011.01629.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with Cryopyrin Associated Periodic Syndromes","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arth Rheum"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2011.01629.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1756-185X.2011.01629.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T15:08:34Z","timestamp":1686236914000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2011.01629.x"}},"subtitle":["Anakinra in refractory chronic tophaceous gout"],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2011.01629.x","relation":{},"ISSN":["1756-1841"],"issn-type":[{"value":"1756-1841","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}